Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Advantage Silver Dental Arrest, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- UALMADRE9GM5
- Solicitation number
- PHS2007-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): The overall purpose of this Phase I SBIR application is conduct of research to address the scientific and technical feasibility of using diammine (also spelled diamine in the literature) silver fluoride as a topical age
nt to arrest the progression of tooth decay, and to conduct the initial work that, in the longer run, will result in FDA 510 K approval of an indication for diammine silver fluoride as a tooth decay arresting agent. The research will be conducted by a coll
aboration of the small business firm ADP Silver Dental Arrest, LLC, and experienced researchers at the University of Connecticut School of Dental Medicine. The Specific Aims are to: 1) Use a human caries model experiment in well-characterized rats to deter
mine whether a single brief topical diammine silver fluoride treatment can inhibit the progression of already-established extensive carious lesions and 2) Conduct a single dose topical administration study to assess potential toxicity of diammine silver fl
uoride. Alarming new national epidemiologic data documents the increase in tooth decay in preschool children (Dye et al., 2007) at the same that there are serious inequities in access to care for the poor and for minorities. The same problem exists for the
elderly and institutionalized where inexpensive solutions to arresting root caries are badly needed. Given increased disease impact in some parts of the population coupled with poor access, it is likely that the disparities will increase. New technology i
s not being developed and brought to the marketplace fast enough to address the problem. Public Health Significance: The overall purpose of this Phase I SBIR application is conduct of research to address the scientific and technical feasibility of using di
ammine (also spelled diamine in the literature) silver fluoride as a topical agent to arrest the progression of tooth decay, and to conduct the initial work that, in the longer run, will result in FDA 510 K approval of an indication for diammine silver flu
oride as a tooth decay arresting agent.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
5 SBIR/STTR records share this UEI (2008–2021). Reported award amounts total $704,168. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards